Escherichia coli strains from swine origin, either susceptible or resistant to colistin, were grown under planktonic and biofilm cultures. After which, they were treated with antibacterial agents including nisin and enterocin DD14 bacteriocins, colistin and their combinations. Importantly, the combination of colistin, enterocin DD14 and nisin eradicated the planktonic and biofilm cultures of E. coli CIP54127 and the E. coli strains with colistin-resistance phenotype such as E. coli 184 (mcr-1(+)) and E. coli 289 (mcr-1(-)), suggesting therefore that bacteriocins from lactic acid bacteria could be used as agents with antibiotic augmentation capability
Introduction Acinetobacter baumannii has attained an alarming level of resistance to antibacterial d...
Limited antimicrobial agents are available for the treatment of implant-associated infections caused...
The role of antibiotics in the treatment of Shiga-like toxin (Stx)-producing E. coli infection is st...
Escherichia coli strains from swine origin, either susceptible or resistant to colistin, were grown ...
The emergence of pan-resistant strains of Gram-negative pathogens and the ability of many bacteria t...
The widespread multidrug-resistant Enterobacteriaceae pose a serious therapeutic challenge. Colistin...
The significant prevalence of Gram-negative bacteria as health-care associated pathogens and their i...
Colistin (COL), the last line of defense in clinical medicine, is an important therapeutic option ag...
[english] Aim: The in vitro activity of colistin in combination with sulbactam, netilmicin, and vanc...
Stenotrophomonas maltophilia is an emerging global opportunistic pathogen, responsible for a wide ra...
<p>Effect of colicins E1, E6, E7, K and M on uroseptic strains UL209 (a) and UL141 (b). All colicins...
Enterococcus faecalis rank among the leading causes of nosocomial infections worldwide and possesses...
Escherichia coli and Salmonella Typhimurium are bacteria that present risks to human health, being a...
The Enterobacter cloacae complex (ECC) is a group of nosocomial pathogens that pose a challenge in c...
The emergence of multidrug resistant (MDR) pathogenic bacteria is jeopardizing the value of antimicr...
Introduction Acinetobacter baumannii has attained an alarming level of resistance to antibacterial d...
Limited antimicrobial agents are available for the treatment of implant-associated infections caused...
The role of antibiotics in the treatment of Shiga-like toxin (Stx)-producing E. coli infection is st...
Escherichia coli strains from swine origin, either susceptible or resistant to colistin, were grown ...
The emergence of pan-resistant strains of Gram-negative pathogens and the ability of many bacteria t...
The widespread multidrug-resistant Enterobacteriaceae pose a serious therapeutic challenge. Colistin...
The significant prevalence of Gram-negative bacteria as health-care associated pathogens and their i...
Colistin (COL), the last line of defense in clinical medicine, is an important therapeutic option ag...
[english] Aim: The in vitro activity of colistin in combination with sulbactam, netilmicin, and vanc...
Stenotrophomonas maltophilia is an emerging global opportunistic pathogen, responsible for a wide ra...
<p>Effect of colicins E1, E6, E7, K and M on uroseptic strains UL209 (a) and UL141 (b). All colicins...
Enterococcus faecalis rank among the leading causes of nosocomial infections worldwide and possesses...
Escherichia coli and Salmonella Typhimurium are bacteria that present risks to human health, being a...
The Enterobacter cloacae complex (ECC) is a group of nosocomial pathogens that pose a challenge in c...
The emergence of multidrug resistant (MDR) pathogenic bacteria is jeopardizing the value of antimicr...
Introduction Acinetobacter baumannii has attained an alarming level of resistance to antibacterial d...
Limited antimicrobial agents are available for the treatment of implant-associated infections caused...
The role of antibiotics in the treatment of Shiga-like toxin (Stx)-producing E. coli infection is st...